What you'll learn

  • Identify current and emerging approaches to early detection, screening, and prevention of hereditary breast, ovarian, pancreatic, and prostate cancers associated with mutations in the BRCA pathway. 

  • Recognize and analyze the latest clinical and translational discoveries in the treatment of breast, ovarian, pancreatic, and prostate cancers associated with hereditary or acquired mutations in BRCA1/2 and related genes. 

  • Discuss current ethical, legal, social as well as diversity and inclusion issues related to carriers of BRCA1/2 and related genes. 

Learn More

Course description

Who Should Attend

  • Specialty Physicians
  • Researchers
  • Clinicians 
  • Other

Learn More
Enroll now. Learn More

You may also like

Internal medicine.
Health & Medicine
Online Live

Update in Internal Medicine

All of the major subspecialties in general medicine will be covered including hot-off-the-press emerging topics, arming you with the latest information.
Price
$1,599
Registration Deadline
Starts Dec 7
A health care provider holding a tablet with an outline of the kidneys.
Health & Medicine
In-Person
Online Live

Conservative Kidney Management: Masterclass

Advance your expertise in conservative kidney management (CKM) by joining an immersive, interprofessional masterclass. Gain evidence-based insights, practical skills, and collaborative strategies to deliver high-quality, patient-centered CKM.
Price
$100
Registration Deadline
An illustration of a heart with a heart beat behind it.
Health & Medicine
In-Person

Heart Failure Summit

Explore comprehensive, multidisciplinary strategies for managing heart failure—from outpatient care to advanced therapies—through expert-led sessions, case studies, and patient perspectives in this Harvard Medical School–accredited one-day summit.
Price
$100
Registration Deadline